Observations placeholder
Simponi
Identifier
020031
Type of Spiritual Experience
Number of hallucinations: 13
Background
A description of the experience
Golimumab (CNTO 148 is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.
On Dec, 11, 2016 15,387 people reported to have side effects when taking Simponi.
Among them, 13 people (0.08%) have Hallucination
Time on Simponi when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Simponi :
| Female | Male | |
| Hallucination | 100.00% | 0.00% |
On Feb, 8, 2016: 2,778 people reported to have side effects when taking Simponi. Among them, 29 people (1.04%) have Death.
Time on Simponi when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 0.00% | 75.00% | 0.00% | 25.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Simponi :
| Female | Male | |
| Death | 59.38% | 40.62% |
Age of people who have Death when taking Simponi :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.32% | 31.58% | 42.11% |
Top conditions involved for these people :
- Rheumatoid arthritis (20 people, 68.97%)
- Crohn's disease (6 people, 20.69%)
- Ankylosing spondylitis (6 people, 20.69%)
- Osteoporosis (1 people, 3.45%)